Real-World Cost-analysis of Paliperidone Palmitate for Schizophrenia Management:A Retrospective Analysis in Xiamen, China
Economics of First-line Treatment with Tislelizumab in Patients with Nonsquamous Non-small Cell Lung Cancer: A Four-state Markov Model
Valuating the efficiency of social security and healthcare in OECD countries from a sustainable development
Cost-Utility Analysis of Prenatal Diagnosis of Congenital Cardiac Diseases using Deep Learning
Cost-effectiveness of Trastuzumab emtansine and Capecitabine plus lapatinib in adjuvant treatment of Human Epidermal Growth Factor Receptor 2– Positive Metastatic Breast Cancer in China
Cost effectiveness and decision analysis for national airport screening options to reduce risk of COVID-19 introduction in Uganda, 2020
Cost-effectiveness analysis of immune checkpoint inhibitors for first-line treatment of advanced esophageal squamous cell carcinoma based on fractional polynomial network meta-analysis
Economic Burden of Atrial Fibrillation Disease in Iran
Cost-effectiveness analysis of haemodialysis and comprehensive conservative care in managing end-stage renal disease in Abuja, Nigeria
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer: a cost-effectiveness analysis
Learn more about Cost Effectiveness and Resource Allocation